Mesto dezagregantov v sisteme vtorichnoy profilaktiki ishemicheskogo insul'ta u detey i molodykh bol'nykh


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article describes the current data and debating points on the indications, dosage and duration of therapy with aspirin and clopidogrel in stroke young patients and children. Recommended dosage for children is 1-3 for aspirin and 0.2-2.0 mg/kg/day for clopidogrel. The authors provide their own data on the six-year follow-up of 82 children with acute ischemic cerebrovascular insufficiency, who received antithrombotic therapy. The high efficiency (twofold reduction of recurrence of thrombotic events) and safety of the proposed scheme for medical support of patients is demonstrated.

全文:

受限制的访问

作者简介

O. L'vova

Email: olvova@bk.ru

V. Gusev

Email: gusev_vadim@inbox.ru

参考

  1. Ganesan V., Prengler M., Wade A., Kirkham F.J. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation. 2006;114:2170-77.
  2. Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008; 39:2644-91.
  3. Se'bire G., Tabarki B., Saunders D.E., et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005;28:477-89
  4. deVeber G., MacGregor D., Curtis R., Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J. Child Neurol. 2000;15:316-24
  5. Ganesan V., Prengler M., McShane M. et al. Investigation of risk factors in children with arterial ischemic stroke. Annals Neurol. 2003;53:167-73.
  6. Калашникова Л.А., Патрушев Л.И., Коваленко Т.Ф. и др. Ишемический инсульт в молодом возрасте и мутации в генах фактора V (мутация Лейдена), протромбина и мет илентетрагидрофолатредуктазы. Журнал неврологии и психиатрии им. С.С.Корсакова. 2003;9:116-18.
  7. Ковтун О.П., Львова О.А., Чегодаев Д.А. Генетически детерминированные нарушения гемокоагуляции как причина ишемических инсультов у детей. Журнал неврологии и психиатрии им. С.С.Корсакова. 2011; 12(Вып. 2):3-9.
  8. Kirkham F.J., Prengler M., Hewes D.K., Ganesan V. Risk factors for arterial ischemic stroke in children. J. Child Neurol. 2000;15:299-307.
  9. Lanthier S., Kirkham F.J., Mitchell L.G., et al. Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology. 2004;62:194-200.
  10. Strater R., Becker S., von Eckardstein A., et al. Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up stud. Lancet. 2002;360:1540-45.
  11. McConnel H. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br. Med. J. 2002;324:71-86.
  12. Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N. Engl. J. Med. 1991;325:1261-66.
  13. Farrel B., Godwin J., et al. The United Kingdom transient ischemic attack (UK-TIA) aspirin trial: final results. J. Neurol. Neurosurg. Phychiatry. 1991;54:1044-54.
  14. Taylor D.W., Barnett H.J.M., et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: randomised con trolled trial. Lancet. 1999;353:2179-83.
  15. Ferguson J.J. III, Gonzalez E.R., Kannel W.B. et al. Clinical safety and efficacy of clopidogrel-implications of the clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) study for future management of atherosclerotic disease. Clin. Ther. 1998;20(suppl B):B42-B53.
  16. Bertrand M.E., Rupprecht H.J., Urban P., Gershlick A.H. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting. Circulation. 2000;102:624-29.
  17. Antiplatelet Therapy: Canadian Best Practice Recommendations for Stroke Care. 4th Edition 2012-2013 [Электронный ресурс]. Режим доступа: http: //www.strokebestpractices.ca/ index.php/prevention-of-stroke/antiplatelet-therapy. 10.07.2014.
  18. Strater R., Kurnik K., Heller C., et al. Aspirin versus low-dose low-molecular-weight heparin. - antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke. 2001;32:2554-58.
  19. Nowak-GottlU.,StraeterR.,SebireG.,KirkhamF.J. Antithrombotic drug treatment of pediatric patients with ischemic stroke. Paediatric Drugs. 2003;5(3):167-75.
  20. Ganesan V., Chong K., Evans J., et al. (The Pediatric Stroke Working Group) «Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation» [Электронный ресурс]. Режим доступа: http://www.rcplon-don.ac.uk/pubs/books/childstroke/childstroke_ guidelines.pdf. 18.07.2014.
  21. Eikelboom J.W., Hirsh J., Weitz J.I., et al. Aspirin resistance and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk of cardiovascular outcomes. Circulation. 2002;105:1650-55.
  22. McKee S.A., Sane D.C., Deliargyris E.N. Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thromb. Haemost. 2002;88:711-15.
  23. Xu Z.H., Jiao J.R., Yang R., et al. Aspirin resis tance: clinical significance and genetic polymorphism. J. Int. Med. Res. 2012;40(1):282-92.
  24. Львова О.А., Ковтун О.П., Кузнецов Н.Н., Вольхина С.А., Баранов Д.А., Пряхина О.П., Зобнина Ю.В. Значимость аллельных вариантов генов системы гемостаза и фолатного цикла у детей с дебютом поражения ЦНС в грудном возрасте. Пермский медицинский журнал. 2012;XXIX(5):51-62.
  25. Buck M.L. Clopidogrel for Platelet Inhibition in Pediatric Patients [Электронный ресурс]. Режим доступа: http: // www.medscape.com/ viewarticle/723239. 21.07.2014.
  26. Soman T.F., Rafay М., Hune S., et al. The Risks and Safety of Clopidogrel in Pediatric Arterial Ischemic Stroke. Stroke. 2006;37:1120-22.
  27. Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children: Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial. Circulation. 2008;117:553-59.
  28. Finkelstein Y., Nurmohamed L., Avner M., et al. Clopidogrel use in children. J. Pediatr. 2005;147:657-61.
  29. Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:887S-968S.
  30. Chabrier S., Kossorotoff M., Darteyre S. Antithrombotic medications and childhood stroke. Presse Med. 2013;42(9 Pt 1):1259-66.
  31. Sibbing D., Braun S., Jawansky S., et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb. Haemost. 2008;99(1):121-26.
  32. Pedersen S.B., Grove E.L., Nielsen H.L., et al. Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry. Platelets. 2009;; 20(6):415-20.
  33. Wurtz M., Hvas A.M., Christensen K.H., et al. Rapid evaluation of platelet function using the Multiplate® Analyzer. Platelets. 2013;Nov 18. [Epub ahead of print].

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2014
##common.cookie##